Nabriva Therapeutics Announces Positive Topline Results from Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis
Stock Information for Nabriva Therapeutics plc
Loading
Please wait while we load your information from QuoteMedia.